Oxford BioMedica PLC buy melinda
Start price
22.09.10
/
50%
€3.00
Target price
22.03.11
€4.50
Performance (%)
-41.67%
End price
22.03.11
€1.75
Summary
This prediction ended on 22.03.11 with a price of €1.75. The BUY prediction by melinda for Oxford BioMedica PLC performed very badly with a performance of -41.67%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Oxford BioMedica PLC | -4.233% | -4.233% | 94.206% | 79.208% |
| iShares Core DAX® | 1.085% | -1.655% | 13.297% | 57.692% |
| iShares Nasdaq 100 | -1.665% | -3.137% | 2.218% | 83.804% |
| iShares Nikkei 225® | 3.863% | 6.947% | 22.818% | 56.282% |
| iShares S&P 500 | 0.111% | -1.320% | 1.445% | 57.791% |
Comments by melinda for this prediction
In the thread Oxford BioMedica PLC diskutieren
Biopharma-
Oxford BioMedica ist ein biopharmazeutisches Unternehmen in der Entwicklung und Kommerzialisierung von innovativen Gen-basierter Medikamente spezialisiert
(Laufzeit überschritten)